Laser ablation treatment for prostate cancer has few to no side effects

Data from the Sperling Prostate Center and the NYU School of Medicine (New York, NY) shows that magnetic resonance imaging (MRI)-guided targeted laser ablation (destruction) of prostate cancer is 96% effective with no urinary or sexual side effects.

Related: Laser ablation method used to treat benign prostate tumors now applied to breast tumors

Of the 25 consecutive patients with low-to-moderate risk cancer who participated in the study, none experienced urinary incontinence at any time. Within three months, all men reported return to pre-treatment sexual function. Follow-up needle biopsies showed no cancer in 96% of the treated tumors.

Focal laser ablation (FLA) is a minimally invasive outpatient procedure that requires no general anesthesia, no surgery, and no radiation. FLA precisely targets any tumor seen on state-of-the-art 3T multiparametric MRI. Recovery is very rapid, with most patients back to normal activity in 1-3 days.

Although not all prostate cancer patients are qualified for FLA, 3T multiparametric MRI identifies suspicious areas with excellent accuracy. Following image detection, a selective targeted biopsy into the area provides a diagnosis. The combination of MRI and biopsy determines if a man is a candidate for FLA. Long-term results have not yet been established in clinical trials. Laser ablation for tumors in soft tissue is FDA-cleared.

Full details of the work appear in the journal European Urology, for more information, please visit http://dx.doi.org/10.1016/j.eururo.2015.04.029.

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

 

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

'Lab on a stick' test optically and rapidly detects antibiotic resistance

A point-of-care test, based on the dipstick method, can rapidly detect bacterial resistance to antibiotics in urine.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS